ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
Pfizer, Eli Lilly’s non-opioid drug helps reduce osteoarthritis pain
biospectrumasia
November 26, 2018A?non-opioid drug?developed by?Pfizer?and?Eli Lilly?met the main goals of a late-stage study, in which over half of the patients reported a significant reduction in?osteoarthritis pain?of the?knee?or?hip. -
Pfizer & Lilly's non-opioid drug reduces pain in osteoarthritis
pharmafile
October 25, 2018Pfizer and Eli Lilly have announced data revealing that their nerve growth factor (NGF) inhibitor tanezumab met all three of its co-primary endpoints in the treatment of osteoarthritis (OA). -
Pfizer, Eli Lilly report detailed results from late-stage study of NGF inhibitor tanezumab in osteoarthritis pain
firstwordpharma
October 25, 2018Pfizer, Eli Lilly report detailed results from late-stage study of NGF inhibitor tanezumab in osteoarthritis pain
Pharma Sources Insight January 2025
